Delivery Order SPE2DB20D1100-SPE2DB25FE1JB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract. The award was issued on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a contract ceiling value of $4,027.70. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 30, 2025, with fulfillment occurring at the vendor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price arrangement. The contract ceiling value is $12,083.10, with an ultimate completion date of October 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a total value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was issued on July 25, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a $8,077.31 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by October 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $4,027.70. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $4,027.70 and a firm fixed price structure. This order is set to be completed by July 30, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ingrezza 40 mg capsules (quantity: 30 units) with a ceiling value of $14,704.48. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1JBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ingrezza 80 mg capsules (30-count) with a contract value of $4,027.70. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. Ingrezza is a prescription antipsychotic medication used to treat involuntary movement disorders associated with antipsychotic use. As a child contract under the DLA's broader pharmaceutical supply framework, this delivery order fulfills immediate medical supply needs for the Defense Health Agency and other government healthcare systems. AmerisourceBergen's status as a major pharmaceutical distributor and prime vendor to the federal government demonstrates its established capacity to meet the stringent requirements of military and veteran healthcare procurement. The firm fixed-price structure and competitive award history reflect the company's ability to deliver pharmaceutical products efficiently while maintaining cost predictability for federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/26/25 |